Our Contributors

Mike O’Brien

Mike O’Brien is an experienced and accomplished employment attorney, media lawyer and courtroom litigator. He consistently has received the highest possible peer reviews from rating services such as Martindale – Hubbell (AV rating) and Chambers USA ("one of the best employer lawyers in Utah"). Utah Business Magazine annually has named him one of Utah’s Legal Elite. He is the immediate past chairman of the firm’s Litigation Department and the leader of its Employment Law and Media Law practice groups. The Utah State Bar named him as its Employment Lawyer of the Year. Mike works with the local and national Society for Human Resource Management (SHRM) and serves as the legal and legislative director for Utah SHRM and Salt Lake SHRM. For such services, National SHRM honored him with its prestigious Capital Award, given annually to one of SHRM’s 170,000 members worldwide. Utah SHRM has given him its Award for Professional Excellence. He is listed in "Best Lawyers in America" for First Amendment (news media) law and employment law and in "Who’s Who Legal USA" as one of the country’s leading attorneys in management employment law. He was also cited in the 2007 editions of "Super Lawyers" for media law and "Chambers USA" for labor and employment law.

Mike partners with employers in many industries to prevent and solve employment problems. Mike is also a recognized media and First Amendment lawyer.

Jason Bhan, MD

Jason Bhan, MD, is Co-Founder and Chief Medical Officer at Prognos, www.prognos.ai, an innovative healthcare AI company. He is an expert in the applications of technology to healthcare and medicine. Dr. Bhan obtained his medical degree at the University of Miami School of Medicine.

Dan Scungio, MT (ASCP), SLS, CQA (ASQ)

Dan Scungio, MT (ASCP), SLS, CQA (ASQ) is laboratory safety officer for Sentara Healthcare Virginia and North Carolina. As Dan the Lab Safety Man, he also serves as a laboratory safety trainer, speaker and consultant. Email: info@danthelabsafetyman.com

Lynne Curry, Ph.D.

Lynne Curry, PhD, SPHR, SHRM-SCP and author of “Beating the Workplace Bully,” AMACOM 2016, and “Solutions” founded The Growth Company, Inc., an Avitus Group company, and is now a Regional Director of Training & Business Consulting for Avitus. Curry regularly presents to the Medical Group Management Association, Alaska Chapter and she and her staff work directly with multiple medical practices and hospitals in Alaska, California and Colorado. Curry and her team provide HR On-call, training, facilitation, strategic planning, investigation, mediation and executive and professional coaching. The Avitus Group has offices from coast to coast.

Jennifer (McMahon) Dawson, MHA, DLM (ASCP)

Jennifer Dawson, MHA, LSSBB, CPHQ, DLM(ASCP)SLS, QLC, QIHC is a Lab Quality Management Leader and advocate for lab quality and patient safety. She is Senior Director, Quality, for Human Longevity, Inc.; Affiliate Faculty, Health Services Administration at Regis University; and a Lab Quality Consultant.

Ms. Dawson sits on the CLMA Board of Directors, the CLSI Quality Management Systems & General Practices Expert Panel, and the AACC Management Sciences & Patient Safety Division. She also serves on the National Malcolm Baldrige Quality Award Board of Examiners and serves on the ASCLS Patient Safety Committee and the AACC Management Sciences and Patient Safety Executive Committee.

William A. Schiemann, Ph.D

William A. Schiemann, Ph.D. is CEO of Metrus Group. He is a thought leader in human resources, employee engagement, and fulfillment and author of Fulfilled! Critical Choices – Work, Home, Life. For more information visit, www.wschiemann.com, follow Dr. Schiemann on Twitter, @wschiemann and connect with him on LinkedIn at www.linkedin.com/in/wmschiemann.

Robert Mazer

I am a Shareholder with Baker Donelson experienced in assisting acute care and critical access hospitals, clinical laboratories and other health care providers with third-party payment, compliance and regulatory issues. I help clients develop business strategies that are practical, will accomplish their legitimate business objectives, and will comply with relevant laws and regulations. This includes laboratory discount, lab to lab referral, and other billing arrangements.

I assist providers involved in disputes related to third-party payments and regulatory compliance, including overpayment demands based on medical necessity determinations. I have extensive experience before the Provider Reimbursement Review Board, most recently related to CAH claims for home office costs, and in challenging sanctions under the Clinical Laboratory Improvement Amendments, particularly related to alleged proficiency testing referrals. My efforts have resulted in favorable settlements and ground breaking victories.

It’s my experience that a good collaborative arrangement between client and attorney leads to the best possible result. I bring to bear extensive knowledge and experience regarding industry practices and legal and regulatory authorities. I also understand financial issues, and may be the only practicing attorney to have served on the AICPA health care committee.

I also organize and participate in the Laboratory Immersion Session at the HCCA Compliance Institute.
Practice Focus:

  • Assisting hospitals, clinical laboratories and other health care providers with payment, compliance and regulatory issues.
  • Working to help providers obtain (or keep) Medicare and other third-party payments for services provided.

When not working, I’m spending time with my wife and goldendoodle, playing tennis (badly), enjoying portrait photography or growing Japanese Maples.

Nick Hernandez

Nick Hernandez, MBA, FACHE is the CEO and founder of ABISA, LLC, a consultancy specializing in healthcare strategic growth initiatives. He is a speaker, trainer, and author who has over 20 years of leadership and operations experience. Since founding ABISA in 2007, his emphasis has been on developing and maintaining a strong relationship with physicians and identifying areas for business opportunity and support. The company’s client list includes physician groups, hospital systems, healthcare IT organizations, venture capitalists, private equity investment groups, and hedge funds. He can be reached at nhernandez@abisallc.com or you can follow him on Twitter: @ABISALLC.

Lâle White, CEO, XIFIN, Inc.

Lâle White is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 25 years of experience in information systems development and medical billing. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the US. She worked with HCFA and the US Office of the Inspector General to develop the first OIG Model Compliance Program. Lâle was previously Vice President – Finance of Laboratory Corporation of America (NYSE: LH), one of the largest clinical reference laboratories in the US, and its predecessor National Health Laboratories (NYSE: NHLI), where she led the software development of several accounts receivable, inventory, cost accounting and financial management systems for the laboratory industry. Lâle has a BA in finance and an MBA from Florida International University. She previously served on the Board of Directors for bioTheranostics, part of the worldwide bioMerieux group, and is currently a member of the Board of Directors for CombiMatrix Corporation, a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders. Lâle is a finalist in the San Diego Business Journal 2017 Most Admired CEO Awards.

Kyle Fetter, VP & General Manager of Diagnostic Services, XIFIN, Inc.

Kyle Fetter has implemented and overseen the commercialization, billing, and reimbursement processes for over 70 unique molecular diagnostic companies releasing new high complexity laboratory testing services onto the health care market. He currently provides strategic direction as well as oversees the implementation process for molecular diagnostic companies at various stages of commercialization and third party payer contracting. He also oversees the development and commercialization of new web-based software products at XIFIN catered to high complexity testing laboratories. In addition to actively working with XIFIN’s large molecular diagnostic billing department, he consults with molecular diagnostic companies on projecting cash flow for non-covered services, implementing successful appeals strategies, and how to effectively manage the relationship between sales and reimbursement for new medical technology. Kyle regularly provides insights into the changing landscape of molecular diagnostic reimbursement via webinars, conferences, and XIFIN’s blog. He came to the healthcare industry with a background in technology funding and commercialization. Kyle has a B.A. from the University of Southern California and an M.B.A from the University of Utah.